Shengxiang Fu

12PUBLICATIONS
15CO-AUTHORS
NanomaterialsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Characterisation of biological macromoleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 14, 2026
Rutin-Doped Hybrid Nanoparticles: Effect of the Molecular Doping Density on <i>T</i><sub>1</sub> Relaxivity and Their Application in Targeted Magnetic Resonance Imaging of Malignant Tumors.

|Jun 18, 2026
Engineered Cell Membrane-Coated Nanoparticles: A New Strategy for Pancreatic Cancer Therapy.

|Apr 16, 2026
T‑Cell Immunoreceptor with Ig and Immunoreceptor Tyrosine-Based Inhibitory Motif Domains/Cluster of Differentiation 40 Cellular Nanovesicles Carrying Oxaliplatin Exhibited Superior Pancreatic Cancer Cells Therapy.

|Jan 06, 2026
Macrocyclic Pyclen-Based Hybrid Nanoprobes for Magnetic Resonance Imaging of Sentinel Lymph Node Metastasis.

Haojie Gu, Yuting Jiang, Zhongyuan Cai

|Jan 08, 2025
Platinum(IV)-Backboned Polymer Prodrug-Functionalized Manganese Oxide Nanoparticles for Enhanced Lung Cancer Chemoimmunotherapy via Amplifying Stimulator of Interferon Genes Activation.

Li Liu, Shengxiang Fu, Haojie Gu

|Oct 14, 2024
One-Pot Fabrication of Kinetically Inert Ultrasmall Manganese(II) Chelate-Backboned Polymer Contrast Agents for High-Performance Magnetic Resonance Imaging.

Shengxiang Fu, Muhammad Rizwan Younis, Zhongyuan Cai

Pageof 2

Frequent Collaborators

9 joint publications

Hua Ai

3 joint publications

Yuting Jiang

3 joint publications

Jiang Zhu

3 joint publications

Hsiang-I Tsai